Work

103eP Efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) combined with tislelizumab and regorafenib for advanced intrahepatic cholangiocarcinoma (ICC): A single-arm, open-label, phase II study

Year: 2025

Type: article

Authors: H. Yu, X. Mo, J. Han, W. Wang, X. Chen, J. Liu, W.M. Ma, S. Wang, C. Peng, Y. Li, T. Zhang, Y. Lu, J. Cheng

Language: English

Subfield: Surgery

Open Access status: bronze

OpenAlex ID: W4415940317

FWCI:

Cites:

Cited by:

Related to: 10